123 related articles for article (PubMed ID: 18726574)
1. Serum stability of peptides.
Jenssen H; Aspmo SI
Methods Mol Biol; 2008; 494():177-86. PubMed ID: 18726574
[TBL] [Abstract][Full Text] [Related]
2. Discovering and improving novel peptide therapeutics.
McGregor DP
Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
[TBL] [Abstract][Full Text] [Related]
3. Peptide-based drug design: here and now.
Otvos L
Methods Mol Biol; 2008; 494():1-8. PubMed ID: 18726565
[TBL] [Abstract][Full Text] [Related]
4. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
5. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
Merrell K; Thulin CD; Esplin MS; Graves SW
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
[TBL] [Abstract][Full Text] [Related]
6. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs.
Cherkasov A; Hilpert K; Jenssen H; Fjell CD; Waldbrook M; Mullaly SC; Volkmer R; Hancock RE
ACS Chem Biol; 2009 Jan; 4(1):65-74. PubMed ID: 19055425
[TBL] [Abstract][Full Text] [Related]
7. A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.
Arenas G; Guzmán F; Cárdenas C; Mercado L; Marshall SH
Peptides; 2009 Aug; 30(8):1405-11. PubMed ID: 19481126
[TBL] [Abstract][Full Text] [Related]
8. The proteolytic stability and cytotoxicity studies of L-aspartic acid and L-diaminopropionic acid derived beta-peptides and a mixed alpha/beta-peptide.
Ahmed S; Kaur K
Chem Biol Drug Des; 2009 May; 73(5):545-52. PubMed ID: 19317848
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
[TBL] [Abstract][Full Text] [Related]
10. Peptide therapeutics: current status and future directions.
Fosgerau K; Hoffmann T
Drug Discov Today; 2015 Jan; 20(1):122-8. PubMed ID: 25450771
[TBL] [Abstract][Full Text] [Related]
11. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
Zhang G; Han B; Lin X; Wu X; Yan H
J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567
[TBL] [Abstract][Full Text] [Related]
12. Rapid profiling of peptide stability in proteolytic environments.
Gorris HH; Bade S; Röckendorf N; Albers E; Schmidt MA; Fránek M; Frey A
Anal Chem; 2009 Feb; 81(4):1580-6. PubMed ID: 19159331
[TBL] [Abstract][Full Text] [Related]
13. Development of low cost pulmonary surfactants composed of a mixture of lipids or lipids-peptides using higher aliphatic alcohol or soy lecithin.
Yukitake K; Nakamura Y; Kawahara M; Nakahara H; Shibata O; Lee S
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):281-6. PubMed ID: 18762408
[TBL] [Abstract][Full Text] [Related]
14. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.
Bidwell GL; Raucher D
Expert Opin Drug Deliv; 2009 Oct; 6(10):1033-47. PubMed ID: 19637980
[TBL] [Abstract][Full Text] [Related]
16. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling.
Kosugi S; Hasebe M; Entani T; Takayama S; Tomita M; Yanagawa H
Chem Biol; 2008 Sep; 15(9):940-9. PubMed ID: 18804031
[TBL] [Abstract][Full Text] [Related]
17. Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells.
Wang KR; Yan JX; Zhang BZ; Song JJ; Jia PF; Wang R
Cancer Lett; 2009 Jun; 278(1):65-72. PubMed ID: 19233550
[TBL] [Abstract][Full Text] [Related]
18. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
Nan YH; Bang JK; Shin SY
Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
[TBL] [Abstract][Full Text] [Related]
19. New approaches in peptide antibiotics.
Vaara M
Curr Opin Pharmacol; 2009 Oct; 9(5):571-6. PubMed ID: 19734091
[TBL] [Abstract][Full Text] [Related]
20. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
Makovitzki A; Fink A; Shai Y
Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
